Position in INCY
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$1,609,371
+$273,150 QoQ
Shares Held
14,197
0.0% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#365
of 849 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in INCY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GABELLI FUNDS LLC holds $57,798,048 across 32 Biotechnology names. INCY ranks #7 (2.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | APGE |
Apogee Therapeutics, Inc.
|
127,281 | $16,894,007 | |
| 2 | TECH |
BIO-TECHNE Corp
|
189,300 | $13,374,045 | |
| 3 | BBIO |
BridgeBio Pharma, Inc.
|
65,300 | $4,863,544 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
7,891 | $3,919,696 | |
| 5 | HALO |
Halozyme Therapeutics, Inc.
|
46,200 | $3,616,074 | |
| 6 | MRNA |
Moderna, Inc.
|
29,500 | $2,065,885 | |
| 7 | INCY |
Incyte Corp
This page
|
14,197 | $1,609,371 | |
| 8 | ABVX |
Abivax S.A.
|
10,000 | $1,332,600 |
All Filings in INCY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,609,371 | 14,197 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $1,336,221 | 14,197 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $1,402,237 | 14,197 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $1,204,047 | 14,197 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $966,815 | 14,197 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $859,628 | 14,197 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $980,586 | 14,197 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $1,007,165 | 15,237 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $923,666 | 15,237 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $808,974 | 14,200 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $929,292 | 14,800 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $924,320 | 16,000 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $996,000 | 16,000 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $1,156,320 | 16,000 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $1,317,248 | 16,400 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $1,046,248 | 15,700 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,215,520 | 16,000 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $1,310,430 | 16,500 | Shares | Sole | 2022-05-18 | |
| 2021-12-31 | $1,196,420 | 16,300 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $1,017,393 | 14,792 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $992,060 | 11,792 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $1,039,605 | 12,792 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $1,000,270 | 11,500 | Shares | Sole | 2021-02-05 | |
| 2020-09-30 | $987,140 | 11,000 | Shares | Sole | 2020-11-06 | |
| 2020-06-30 | $1,611,535 | 15,500 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $1,464,600 | 20,000 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||